News zum Sektor Gesundheit aus Finnland

 

Terveystalo, Press Release, 9 October 2025   Terveystalo will publish its Interim Report for January-September 2025 on Thursday 23 October 2025 at 9:00 EEST. Materials will be available soon after publication on Terveystalo's IR website.   Terveystalo will arrange a result webcast and conference call in English on the same day, starting at 10:30 EEST. You can watch the webcast online at: https://terveystalo.events.inderes.com/q3-2025   Conference call: You can access the teleconference by registering on the link below. After the registration you will be provided phone...

TAMPERE, Finland, Oct. 1, 2025 /PRNewswire/ -- Bioretec Ltd, a pioneer in absorbable orthopedic implants, announced today that the Centers for Medicare & Medicaid Services (CMS) has granted Transitional Pass-Through Payment (TPT) status for the company's RemeOs™ Screw LAG Solid, effective......

Bioretec Ltd  Press release 1 October 2025 at 15:00 p.m.EET Bioretec Ltd, a pioneer in absorbable orthopedic implants, has been granted Transitional Pass-Through Payment (TPT) status by the U.S. Centers for Medicare & Medicaid Services (CMS) for the company's RemeOsTM Trauma Screw effective October 1, 2025. RemeOs Trauma received TPT status under the alternative pathway for devices with both Breakthrough Device Designation and FDA market authorization. The TPT payment (HCPCS billing code, C1741) provides hospitals and ambulatory surgical centers with additional reimbursement for new and...

ORION CORPORATION PRESS RELEASE 30 SEPTEMBER 2025 at 13.00 EEST        ...

Terveystalo Plc stock exchange release 30 September 2025 at 11:00 a.m. EEST Minttu Sinisalo, a member of Terveystalo's Executive Team and Senior Vice President, People and Careers, has announced that she will leave the company on 31 December 2025 to become Kesko's Senior Vice President, Human Resources. Terveystalo will start the search for Sinisalo's successor immediately. - I would like to warmly thank Minttu Sinisalo and wish her the best of luck in her new position. Minttu has played a key role in supporting Terveystalo's transformation and developing leadership. Her contribution...

Minttu Sinisalo, M.Sc. (Econ.), 45, has been appointed as Executive Vice President, HR and a member of Kesko's Group Management Board as of 1 March 2026. Sinisalo comes to Kesko from Terveystalo, where she currently holds the position of Senior Vice President, HR. Before joining Terveystalo, Sinisalo held various HR leadership positions at Finnair. Kesko's current Executive Vice President of HR Matti Mettälä will retire, as per his agreement, on 1 March 2026. To ensure a smooth transfer of duties, Minttu Sinisalo will join Kesko on 1 January 2026. ”Minttu Sinisalo will bring strong...

ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS30 September 2025 at 9.00 EEST         ...

Optomed Plc - Managers' Transactions – 26 September 2025 at 16.30 EET Optomed Plc - Managers' transactions - Piila ____________________________________________ Person subject to the notification requirement Name: Piila, Laura Position: Other senior manager Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20250926113812_72 ____________________________________________ Transaction date: 2025-09-26 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT...

Optomed Plc - Managers' Transactions – 26 September  2025 at 16.30 EET Optomed Plc - Managers' transactions - Myllylä ____________________________________________ Person subject to the notification requirement Name: Myllylä, Markku Position: Other senior manager Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20250926113812_73 ____________________________________________ Transaction date: 2025-09-26 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT...

Optomed Plc - Managers' Transactions – 26 September 2025 at 16.30 EET Optomed Plc - Managers' transactions - Himberg ____________________________________________ Person subject to the notification requirement Name: Himberg, Juho Position: Chief Executive Officer Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20250926113812_71 ____________________________________________ Transaction date: 2025-09-26 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT...

Optomed Plc - Managers' Transactions – 26 September  2025 at 16.30 EET Optomed Plc - Managers' transactions - Knuutti ____________________________________________ Person subject to the notification requirement Name: Knuutti, Sakari Position: Chief Financial Officer Issuer: Optomed Plc LEI: 7437009IVYWGEE4S7B77 Notification type: INITIAL NOTIFICATION Reference number: 7437009IVYWGEE4S7B77_20250926113812_74 ____________________________________________ Transaction date: 2025-09-26 Venue not applicable Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT...

ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS26 September 2025 at 16.30 EEST         ...

Pihlajalinna Plc      Inside Information      25 September 2025 at 1:00 p.m. EET Inside Information: Pihlajalinna plans to reform its operating model to ensure development and growth in line with the strategy Pihlajalinna Plc is planning to reform its operating model to ensure development and growth in line with its strategy and to respond to business transformation. Pihlajalinna will initiate change negotiations covering the entire group. The new operating model would consist of health services, medical leadership, commercial operations, separately managed business operations such...

Optomed Plc Stock Exchange Release 23 September 2025 at 9.00, Helsinki Optomed's Board has resolved upon a new option plan Optomed's board of directors has resolved upon a new option plan. The resolution is based on the authorization given by the general meeting of 9 May 2025.   Option plan 2025A: The total number of options is 190,000 and each option entitled to one share of the company. The options are offered to certain key employees. The purpose of the plan is to retain and incentifize the CEO and certain other key employees. The subscription price is EUR 3.77. The...

TURKU, FI / ACCESS Newswire / September 19, 2025 / Faron Pharmaceuticals Ltd. (AIM:FARN)(First North:FARON), a clinical-stage biopharmaceutical company focused on developing novel immunotherapies, ......

ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 19 SEPTEMBER 2025 at 9.00 EEST        ...

Pihlajalinna Plc        Stock Exchange Release        18 September 2025 at 9:00 a.m. EET Change in Pihlajalinna's Management Team Anu Kallio, Executive Vice President, Private Healthcare Services at Pihlajalinna Plc, has decided to leave the company. Until further notice, Private Healthcare Services will be led by Seppo Kariniemi, Executive Vice President, Public Services and a member of the Group Management Team. Kallio steps down from the Group Management Team as of today. “I would like to thank Anu for her contribution in leading Pihlajalinna' s Private Healthcare Services. I...

Bioretec Ltd  Company announcement 16 September 2025 at 7.30 p.m. EEST The following persons have been appointed to Bioretec's Shareholders' Nomination Board: Tor-Oskar Karlberg from Stephen Industries Inc Oy, Rami Vehmas from Keskinäinen Eläkevakuutusyhtiö Ilmarinen, and Heinz Moitzi from W&M GmbH. The Nomination Board has elected Tor-Oskar Karlberg as its chairperson at its organizational meeting on September 16, 2025. The chairperson of the Board of Directors of Bioretec acts as an expert to the Nomination Board without voting rights. In accordance with the decision taken by the...

Bioretec Ltd  Inside information 15 September 2025 at 5.30 p.m. EEST Bioretec Ltd., a pioneer in absorbable orthopedic implants appoints Anne-Mari Matikainen as Interim Chief Financial Officer, effective immediately. In this role, Matikainen will report to Chief Executive Officer Sarah van Hellenberg Hubar-Fisher and will join the company's management team. Matikainen brings over 16 years of versatile experience in finance, treasury, and management consulting, having held key positions across corporate and financial sectors, such as CFO leadership experience at Springvest Oyj.  “We are...

Bioretec Ltd Company announcement 15 September 2025 at 3.15 p.m. EEST An aggregate number of 5,000 new shares of Bioretec Ltd have been subscribed for with option rights under option program 2018-1A. The new shares have on 15 September 2025 been registered with the trade register maintained by the Finnish Patent and Registration Office. The total subscription price of EUR 7,100.00 will be recorded in Bioretec's reserve of invested unrestricted equity, and the company's share capital remains unchanged. Following the registration of the new shares, the total number of shares in Bioretec is...